Kathryn M Storey, Lena Shay, Truman Poteat, Kathleen A Pennington, Laura C Schulz
{"title":"Maternal Pre-pregnancy Risks and Postpartum Consequences of Gestational Diabetes.","authors":"Kathryn M Storey, Lena Shay, Truman Poteat, Kathleen A Pennington, Laura C Schulz","doi":"10.1530/REP-25-0050","DOIUrl":null,"url":null,"abstract":"<p><p>Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance that arises during pregnancy. It can be caused by excess insulin resistance, a failure to augment insulin secretion in response to pregnancy, or both. The risk of developing GDM is affected by several maternal morbidities, some of which are modifiable. Personal or family history of GDM or type 2 diabetes is strongly associated with GDM, and some susceptibility alleles for type 2 diabetes are shared with GDM. Social determinants of health including access to care and nutritional availability are also associated with GDM risk. Obesity is particularly associated with insulin resistance and dyslipidemia, which are risk factors for GDM. These factors are also present in Polycystic Ovarian Syndrome (PCOS), and women with this condition have an elevated risk of GDM. While dysfunctional beta cell compensation may also be present prior to pregnancy and predispose to GDM, symptoms only manifest in pregnancy. Other factors that may increase the risk of GDM include folic acid supplementation, age of either parent and interpregnancy interval. Not only are preexisting maternal morbidities associated with development of GDM, women who have experienced a pregnancy complicated by GDM are more likely to develop type 2 diabetes and cardiovascular disease later in life. Whether this relationship is cause-and-effect or due to common underlying risk factors is unknown.</p>","PeriodicalId":21127,"journal":{"name":"Reproduction","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproduction","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1530/REP-25-0050","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DEVELOPMENTAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance that arises during pregnancy. It can be caused by excess insulin resistance, a failure to augment insulin secretion in response to pregnancy, or both. The risk of developing GDM is affected by several maternal morbidities, some of which are modifiable. Personal or family history of GDM or type 2 diabetes is strongly associated with GDM, and some susceptibility alleles for type 2 diabetes are shared with GDM. Social determinants of health including access to care and nutritional availability are also associated with GDM risk. Obesity is particularly associated with insulin resistance and dyslipidemia, which are risk factors for GDM. These factors are also present in Polycystic Ovarian Syndrome (PCOS), and women with this condition have an elevated risk of GDM. While dysfunctional beta cell compensation may also be present prior to pregnancy and predispose to GDM, symptoms only manifest in pregnancy. Other factors that may increase the risk of GDM include folic acid supplementation, age of either parent and interpregnancy interval. Not only are preexisting maternal morbidities associated with development of GDM, women who have experienced a pregnancy complicated by GDM are more likely to develop type 2 diabetes and cardiovascular disease later in life. Whether this relationship is cause-and-effect or due to common underlying risk factors is unknown.
期刊介绍:
Reproduction is the official journal of the Society of Reproduction and Fertility (SRF). It was formed in 2001 when the Society merged its two journals, the Journal of Reproduction and Fertility and Reviews of Reproduction.
Reproduction publishes original research articles and topical reviews on the subject of reproductive and developmental biology, and reproductive medicine. The journal will consider publication of high-quality meta-analyses; these should be submitted to the research papers category. The journal considers studies in humans and all animal species, and will publish clinical studies if they advance our understanding of the underlying causes and/or mechanisms of disease.
Scientific excellence and broad interest to our readership are the most important criteria during the peer review process. The journal publishes articles that make a clear advance in the field, whether of mechanistic, descriptive or technical focus. Articles that substantiate new or controversial reports are welcomed if they are noteworthy and advance the field. Topics include, but are not limited to, reproductive immunology, reproductive toxicology, stem cells, environmental effects on reproductive potential and health (eg obesity), extracellular vesicles, fertility preservation and epigenetic effects on reproductive and developmental processes.